| # | Drug | Count |
|---|---|---|
| 0 | 0XYGEN | 8 |
| 1 | OXYGEN | 8 |
| 2 | NITROUS OXIDE | 6 |
| 3 | DIAZEPAM | 3 |
| 4 | DIAZEPAM ORAL | 3 |
| 5 | DIAZEPAM ORAL SOLUTION (CONCENTRATE) | 3 |
| 6 | ACETAMINOPHEN | 2 |
| 7 | ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE | 2 |
| 8 | AMBRISENTAN | 2 |
| 9 | ATORVASTATIN CALCIUM | 2 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | NITROUS OXIDE | 6 | 0.0027 |
| 1 | EPINEPHRINE HYDROCHLORIDE | 1 | 0.0021 |
| 2 | VELAGLUCERASE ALFA | 1 | 0.0005 |
| 3 | IPRATROPIUM BROMIDE AND ALBUTEROL | 1 | 0.0004 |
| 4 | TIOTROPIUM BROMIDE AND OLODATEROL | 1 | 0.0002 |
| 5 | ACOLTREMON | 1 | 0.0002 |
| 6 | 0XYGEN | 8 | 0.0002 |
| 7 | OXYGEN | 8 | 0.0002 |
| 8 | BENAZEPRIL HYDROCHLORIDE | 1 | 0.0001 |
| 9 | PYRIDOSTIGMINE BROMIDE | 1 | 0.0001 |
| # | Drug class | Count |
|---|---|---|
| 0 | Benzodiazepine [EPC] | 3 |
| 1 | Corticosteroid [EPC] | 3 |
| 2 | Endothelin Receptor Antagonist [EPC] | 3 |
| 3 | Phosphodiesterase 5 Inhibitor [EPC] | 3 |
| 4 | Expectorant [EPC] | 2 |
| 5 | Factor Xa Inhibitor [EPC] | 2 |
| 6 | HMG-CoA Reductase Inhibitor [EPC] | 2 |
| 7 | Prostacycline Vasodilator [EPC] | 2 |
| 8 | Aldosterone Antagonist [EPC] | 1 |
| 9 | Anti-epileptic Agent [EPC] | 1 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Serotonin and Norepinephrine Reuptake Inhibitor [EPC] | 1 | 0.0003 |
| 1 | TRPM8 Thermoreceptor Agonist [EPC] | 1 | 0.0002 |
| 2 | Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC] | 1 | 0.0001 |
| 3 | Provitamin D2 Compound [EPC] | 1 | 0.0000 |
| 4 | Thiazide-like Diuretic [EPC] | 1 | 0.0000 |
| 5 | Phosphodiesterase 5 Inhibitor [EPC] | 3 | 0.0000 |
| 6 | beta3-Adrenergic Agonist [EPC] | 1 | 0.0000 |
| 7 | Complement Inhibitor [EPC] | 1 | 0.0000 |
| 8 | Endothelin Receptor Antagonist [EPC] | 3 | 0.0000 |
| 9 | Prostacycline Vasodilator [EPC] | 2 | 0.0000 |